

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 6.33391773 |
| 2 | lymphangiogenesis (GO:0001946) | 4.75911605 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.72120127 |
| 4 | positive regulation of protein kinase C signaling (GO:0090037) | 4.47083226 |
| 5 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.39385571 |
| 6 | endocardial cushion morphogenesis (GO:0003203) | 4.35322014 |
| 7 | protein heterotrimerization (GO:0070208) | 4.31942632 |
| 8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.23756735 |
| 9 | positive regulation of astrocyte differentiation (GO:0048711) | 3.95555478 |
| 10 | negative regulation of protein localization to cell surface (GO:2000009) | 3.86349429 |
| 11 | dermatan sulfate biosynthetic process (GO:0030208) | 3.76257459 |
| 12 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.75259280 |
| 13 | phenol-containing compound catabolic process (GO:0019336) | 3.60376321 |
| 14 | dermatan sulfate metabolic process (GO:0030205) | 3.58144130 |
| 15 | collagen fibril organization (GO:0030199) | 3.57376410 |
| 16 | vascular smooth muscle contraction (GO:0014829) | 3.53902929 |
| 17 | regulation of cardioblast differentiation (GO:0051890) | 3.48006387 |
| 18 | blood vessel maturation (GO:0001955) | 3.44867424 |
| 19 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.42961018 |
| 20 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.40118891 |
| 21 | axon extension involved in axon guidance (GO:0048846) | 3.39156635 |
| 22 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.39156635 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.36358764 |
| 24 | heart valve formation (GO:0003188) | 3.35300189 |
| 25 | * cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.34989063 |
| 26 | glial cell migration (GO:0008347) | 3.34457091 |
| 27 | glucocorticoid biosynthetic process (GO:0006704) | 3.34426975 |
| 28 | endothelium development (GO:0003158) | 3.33687105 |
| 29 | positive regulation of extracellular matrix organization (GO:1903055) | 3.31078597 |
| 30 | negative regulation of hormone metabolic process (GO:0032351) | 3.29720189 |
| 31 | cellular response to cholesterol (GO:0071397) | 3.26436753 |
| 32 | hormone catabolic process (GO:0042447) | 3.20670430 |
| 33 | response to follicle-stimulating hormone (GO:0032354) | 3.19128184 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17062294 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.16431129 |
| 36 | response to lead ion (GO:0010288) | 3.12276265 |
| 37 | phagocytosis, recognition (GO:0006910) | 3.09808204 |
| 38 | complement activation, classical pathway (GO:0006958) | 3.09749208 |
| 39 | apoptotic cell clearance (GO:0043277) | 3.09280437 |
| 40 | epoxygenase P450 pathway (GO:0019373) | 3.08591178 |
| 41 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.04255887 |
| 42 | basement membrane organization (GO:0071711) | 3.04232645 |
| 43 | cardiac myofibril assembly (GO:0055003) | 3.03034972 |
| 44 | chondrocyte proliferation (GO:0035988) | 3.01608249 |
| 45 | omega-hydroxylase P450 pathway (GO:0097267) | 3.01577930 |
| 46 | growth hormone receptor signaling pathway (GO:0060396) | 3.01329146 |
| 47 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.99925148 |
| 48 | regulation of endothelial cell differentiation (GO:0045601) | 2.98655168 |
| 49 | chondroitin sulfate catabolic process (GO:0030207) | 2.96070694 |
| 50 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.95933190 |
| 51 | negative regulation of platelet activation (GO:0010544) | 2.93692756 |
| 52 | cell adhesion mediated by integrin (GO:0033627) | 2.93279914 |
| 53 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.92824894 |
| 54 | regulation of relaxation of muscle (GO:1901077) | 2.92014518 |
| 55 | opsonization (GO:0008228) | 2.91451809 |
| 56 | presynaptic membrane assembly (GO:0097105) | 2.90428675 |
| 57 | virion attachment to host cell (GO:0019062) | 2.89833631 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 2.89833631 |
| 59 | extracellular fibril organization (GO:0043206) | 2.89544836 |
| 60 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.89456928 |
| 61 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.88865746 |
| 62 | relaxation of cardiac muscle (GO:0055119) | 2.88775428 |
| 63 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.88022155 |
| 64 | collagen metabolic process (GO:0032963) | 2.87727182 |
| 65 | complement activation (GO:0006956) | 2.87568166 |
| 66 | bone trabecula formation (GO:0060346) | 2.86061141 |
| 67 | otic vesicle formation (GO:0030916) | 2.83792780 |
| 68 | adhesion of symbiont to host (GO:0044406) | 2.83683538 |
| 69 | extracellular matrix assembly (GO:0085029) | 2.82817366 |
| 70 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.82773269 |
| 71 | cell communication by electrical coupling (GO:0010644) | 2.82543602 |
| 72 | complement activation, alternative pathway (GO:0006957) | 2.82409942 |
| 73 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.81729069 |
| 74 | collagen catabolic process (GO:0030574) | 2.80982825 |
| 75 | endothelial cell morphogenesis (GO:0001886) | 2.80845191 |
| 76 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.79395903 |
| 77 | cellular response to sterol (GO:0036315) | 2.78491962 |
| 78 | venous blood vessel morphogenesis (GO:0048845) | 2.78414346 |
| 79 | endothelial cell chemotaxis (GO:0035767) | 2.76907054 |
| 80 | cell proliferation involved in kidney development (GO:0072111) | 2.76615683 |
| 81 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.76583317 |
| 82 | hyaluronan catabolic process (GO:0030214) | 2.76511702 |
| 83 | positive regulation of macrophage cytokine production (GO:0060907) | 2.76056801 |
| 84 | cellular response to interferon-alpha (GO:0035457) | 2.75150336 |
| 85 | radial glial cell differentiation (GO:0060019) | 2.73815195 |
| 86 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.71732167 |
| 87 | oligodendrocyte differentiation (GO:0048709) | 2.71604798 |
| 88 | fibril organization (GO:0097435) | 2.69764148 |
| 89 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.69328978 |
| 90 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.68073830 |
| 91 | regulation of cellular extravasation (GO:0002691) | 2.67880467 |
| 92 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.67446089 |
| 93 | heart valve morphogenesis (GO:0003179) | 2.66287891 |
| 94 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.65994827 |
| 95 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.65987238 |
| 96 | regulation of the force of heart contraction (GO:0002026) | 2.65826284 |
| 97 | regulation of monocyte chemotaxis (GO:0090025) | 2.65663910 |
| 98 | cell migration involved in heart development (GO:0060973) | 2.64786575 |
| 99 | positive regulation of calcium ion import (GO:0090280) | 2.63505310 |
| 100 | cholesterol biosynthetic process (GO:0006695) | 2.63226338 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62137208 |
| 102 | regulation of axon guidance (GO:1902667) | 2.60804758 |
| 103 | myofibril assembly (GO:0030239) | 2.59180345 |
| 104 | nephron tubule formation (GO:0072079) | 2.58996364 |
| 105 | cell proliferation involved in metanephros development (GO:0072203) | 2.58650487 |
| 106 | Notch signaling involved in heart development (GO:0061314) | 2.57916184 |
| 107 | substrate-dependent cell migration (GO:0006929) | 2.57650570 |
| 108 | skin morphogenesis (GO:0043589) | 2.57228449 |
| 109 | eye photoreceptor cell differentiation (GO:0001754) | 2.56765238 |
| 110 | photoreceptor cell differentiation (GO:0046530) | 2.56765238 |
| 111 | regulation of actin filament-based movement (GO:1903115) | 2.56573516 |
| 112 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.55887871 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.55778146 |
| 114 | endodermal cell differentiation (GO:0035987) | 2.54919393 |
| 115 | cellular response to growth hormone stimulus (GO:0071378) | 2.54035065 |
| 116 | sodium ion export (GO:0071436) | 2.53195626 |
| 117 | phenylpropanoid metabolic process (GO:0009698) | 2.52841083 |
| 118 | multicellular organismal catabolic process (GO:0044243) | 2.52287558 |
| 119 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.52164405 |
| 120 | regulation of apoptotic cell clearance (GO:2000425) | 2.51553736 |
| 121 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51068456 |
| 122 | smooth muscle tissue development (GO:0048745) | 2.50442696 |
| 123 | extracellular matrix disassembly (GO:0022617) | 2.50406343 |
| 124 | multicellular organismal metabolic process (GO:0044236) | 2.49805335 |
| 125 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48790428 |
| 126 | hyaluronan metabolic process (GO:0030212) | 2.48544753 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.47743564 |
| 128 | ganglion development (GO:0061548) | 2.47453389 |
| 129 | cGMP-mediated signaling (GO:0019934) | 2.47198103 |
| 130 | germ cell migration (GO:0008354) | 2.45718699 |
| 131 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.45536413 |
| 132 | keratan sulfate catabolic process (GO:0042340) | 2.44519525 |
| 133 | limb bud formation (GO:0060174) | 2.44413364 |
| 134 | regulation of calcium ion import (GO:0090279) | 2.44036347 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.43295251 |
| 136 | potassium ion import (GO:0010107) | 2.42826815 |
| 137 | glycosaminoglycan catabolic process (GO:0006027) | 2.42226443 |
| 138 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.41962772 |
| 139 | phospholipid homeostasis (GO:0055091) | 2.38793465 |
| 140 | mesenchyme morphogenesis (GO:0072132) | 2.38092182 |
| 141 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.37615749 |
| 142 | regulation of extracellular matrix organization (GO:1903053) | 2.37446268 |
| 143 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.37428895 |
| 144 | neuronal stem cell maintenance (GO:0097150) | 2.36925846 |
| 145 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.36861204 |
| 146 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.36745371 |
| 147 | negative regulation of leukocyte migration (GO:0002686) | 2.36243867 |
| 148 | endothelial cell migration (GO:0043542) | 2.35663690 |
| 149 | cellular response to gonadotropin stimulus (GO:0071371) | 2.34498951 |
| 150 | protein activation cascade (GO:0072376) | 2.34415177 |
| 151 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.34005644 |
| 152 | positive regulation of osteoblast proliferation (GO:0033690) | 2.33788655 |
| 153 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.33564565 |
| 154 | blood vessel endothelial cell migration (GO:0043534) | 2.33298092 |
| 155 | glomerular filtration (GO:0003094) | 2.32088861 |
| 156 | endothelial cell differentiation (GO:0045446) | 2.31853249 |
| 157 | regulation of platelet activation (GO:0010543) | 2.31844904 |
| 158 | reverse cholesterol transport (GO:0043691) | 2.31263146 |
| 159 | endothelial cell proliferation (GO:0001935) | 2.31169195 |
| 160 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.30715165 |
| 161 | mesenchymal cell proliferation (GO:0010463) | 2.29270850 |
| 162 | * extracellular matrix organization (GO:0030198) | 2.29078096 |
| 163 | barbed-end actin filament capping (GO:0051016) | 2.28791563 |
| 164 | aminoglycan catabolic process (GO:0006026) | 2.28605606 |
| 165 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.28564711 |
| 166 | regulation of macrophage cytokine production (GO:0010935) | 2.28101822 |
| 167 | * extracellular structure organization (GO:0043062) | 2.28080977 |
| 168 | atrioventricular valve morphogenesis (GO:0003181) | 2.27469279 |
| 169 | negative chemotaxis (GO:0050919) | 2.26519000 |
| 170 | sterol biosynthetic process (GO:0016126) | 2.26493994 |
| 171 | regulation of mononuclear cell migration (GO:0071675) | 2.26261010 |
| 172 | atrial septum morphogenesis (GO:0060413) | 2.26056790 |
| 173 | regulation of protein activation cascade (GO:2000257) | 2.25717669 |
| 174 | low-density lipoprotein particle remodeling (GO:0034374) | 2.25690445 |
| 175 | phagocytosis, engulfment (GO:0006911) | 2.25319669 |
| 176 | retinal metabolic process (GO:0042574) | 2.24890938 |
| 177 | regulation of complement activation (GO:0030449) | 2.23806182 |
| 178 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.23331939 |
| 179 | C4-dicarboxylate transport (GO:0015740) | 2.21951704 |
| 180 | cardiac chamber formation (GO:0003207) | 2.21896360 |
| 181 | thyroid hormone generation (GO:0006590) | 2.21878111 |
| 182 | toxin transport (GO:1901998) | 2.21460535 |
| 183 | negative regulation of astrocyte differentiation (GO:0048712) | 2.20833627 |
| 184 | glucocorticoid metabolic process (GO:0008211) | 2.20732411 |
| 185 | adrenal gland development (GO:0030325) | 2.19670420 |
| 186 | cellular sodium ion homeostasis (GO:0006883) | 2.18230979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.95284673 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88481979 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.79021782 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.73218654 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.64832906 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.61874467 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.58730514 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51987267 |
| 9 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.41182117 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.27876516 |
| 11 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.23619970 |
| 12 | CJUN_26792858_Chip-Seq_BT549_Human | 2.19191369 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17354570 |
| 14 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12939914 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11138987 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.07741380 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06214819 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.04035718 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03126135 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91690022 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90107939 |
| 22 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.89484626 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89372200 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85110277 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83279112 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.81197874 |
| 27 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.79618366 |
| 28 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.79618366 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.79372223 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74930704 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.72504796 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.70725220 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69244666 |
| 34 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68690456 |
| 35 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67944645 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64287497 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62309642 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.58969835 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58943498 |
| 40 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.58061776 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55454067 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55291347 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52408893 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51964944 |
| 45 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.51923088 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51325492 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48876968 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48131511 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47631248 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46702477 |
| 51 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.45222611 |
| 52 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44212252 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44110676 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43985705 |
| 55 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42946834 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42667694 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42179349 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41372333 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40199480 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39844406 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38733971 |
| 62 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38721585 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37942626 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36747469 |
| 65 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34737356 |
| 66 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.34690511 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32586348 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32586348 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31323473 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30987273 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29610273 |
| 72 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.28357372 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26102409 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25577549 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25491265 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24800395 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24745863 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23926262 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22379857 |
| 80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21757852 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21693209 |
| 82 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.20632345 |
| 83 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19608071 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19347778 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18590838 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18006998 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17737614 |
| 88 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16969074 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15794785 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15755326 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14323903 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14260708 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12228153 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12177781 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11702098 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11457242 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11226305 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11214708 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10519762 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10346657 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09940945 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09940945 |
| 103 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09790972 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09635703 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09147721 |
| 106 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09132493 |
| 107 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08475681 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07320276 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07053118 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07039287 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06587603 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06337707 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06172134 |
| 114 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05913513 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05282841 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05062427 |
| 117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02810035 |
| 118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01025376 |
| 119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00515000 |
| 120 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.00162055 |
| 121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00142374 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99387578 |
| 123 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99098151 |
| 124 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98969927 |
| 125 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98679786 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98675374 |
| 127 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98564391 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98487746 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98336065 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98282750 |
| 131 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.98144367 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98017395 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98017395 |
| 134 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97975419 |
| 135 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97600775 |
| 136 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97240137 |
| 137 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97157728 |
| 138 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96912869 |
| 139 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96807277 |
| 140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96050838 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95817996 |
| 142 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94997451 |
| 143 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94920679 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94427412 |
| 145 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.93500630 |
| 146 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93212985 |
| 147 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92077924 |
| 148 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91989654 |
| 149 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91742704 |
| 150 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91690346 |
| 151 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90169612 |
| 152 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88047089 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87586636 |
| 154 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86921815 |
| 155 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.86075692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.79789362 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.76746572 |
| 3 | MP0006054_spinal_hemorrhage | 4.17587276 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 4.05796654 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.95568431 |
| 6 | MP0003136_yellow_coat_color | 3.70105453 |
| 7 | MP0003279_aneurysm | 3.69704181 |
| 8 | MP0003724_increased_susceptibility_to | 3.53602807 |
| 9 | MP0005275_abnormal_skin_tensile | 3.44208485 |
| 10 | MP0002254_reproductive_system_inflammat | 3.17018825 |
| 11 | MP0004272_abnormal_basement_membrane | 3.01114644 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.98550883 |
| 13 | MP0000566_synostosis | 2.49176286 |
| 14 | MP0001958_emphysema | 2.47652962 |
| 15 | MP0003011_delayed_dark_adaptation | 2.44728075 |
| 16 | MP0008004_abnormal_stomach_pH | 2.36698155 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.32684699 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.28974775 |
| 19 | MP0000462_abnormal_digestive_system | 2.25676559 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.11715107 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.04948478 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.96082569 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.92078155 |
| 24 | MP0000767_abnormal_smooth_muscle | 1.85550295 |
| 25 | MP0002295_abnormal_pulmonary_circulatio | 1.84354123 |
| 26 | MP0005248_abnormal_Harderian_gland | 1.82358110 |
| 27 | MP0005508_abnormal_skeleton_morphology | 1.80389024 |
| 28 | MP0003868_abnormal_feces_composition | 1.72394664 |
| 29 | MP0005187_abnormal_penis_morphology | 1.62350321 |
| 30 | MP0003329_amyloid_beta_deposits | 1.62120194 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.61733694 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.61538656 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.56569735 |
| 34 | MP0000751_myopathy | 1.50212888 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.48935382 |
| 36 | MP0003091_abnormal_cell_migration | 1.46836444 |
| 37 | MP0004858_abnormal_nervous_system | 1.45169603 |
| 38 | MP0003828_pulmonary_edema | 1.45103805 |
| 39 | MP0002933_joint_inflammation | 1.45022960 |
| 40 | MP0002060_abnormal_skin_morphology | 1.44499610 |
| 41 | MP0003385_abnormal_body_wall | 1.43187387 |
| 42 | MP0000639_abnormal_adrenal_gland | 1.41414735 |
| 43 | MP0005023_abnormal_wound_healing | 1.41260339 |
| 44 | MP0005164_abnormal_response_to | 1.40992768 |
| 45 | MP0000343_altered_response_to | 1.38624912 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.37428735 |
| 47 | MP0005390_skeleton_phenotype | 1.35806750 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.32013102 |
| 49 | MP0005595_abnormal_vascular_smooth | 1.31997313 |
| 50 | MP0000537_abnormal_urethra_morphology | 1.31698361 |
| 51 | MP0004147_increased_porphyrin_level | 1.31081572 |
| 52 | MP0005330_cardiomyopathy | 1.29406859 |
| 53 | MP0001542_abnormal_bone_strength | 1.28584037 |
| 54 | MP0001851_eye_inflammation | 1.27233739 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.27024869 |
| 56 | MP0005623_abnormal_meninges_morphology | 1.26903206 |
| 57 | MP0001835_abnormal_antigen_presentation | 1.25726183 |
| 58 | MP0001243_abnormal_dermal_layer | 1.25310119 |
| 59 | MP0000538_abnormal_urinary_bladder | 1.22336802 |
| 60 | MP0001984_abnormal_olfaction | 1.21374318 |
| 61 | MP0009840_abnormal_foam_cell | 1.20924527 |
| 62 | MP0009250_abnormal_appendicular_skeleto | 1.20109896 |
| 63 | MP0000604_amyloidosis | 1.18864768 |
| 64 | MP0004883_abnormal_blood_vessel | 1.18638748 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.17841350 |
| 66 | MP0005620_abnormal_muscle_contractility | 1.16845256 |
| 67 | MP0000685_abnormal_immune_system | 1.13793036 |
| 68 | MP0003690_abnormal_glial_cell | 1.13779093 |
| 69 | MP0003303_peritoneal_inflammation | 1.13774572 |
| 70 | MP0000733_abnormal_muscle_development | 1.12391156 |
| 71 | MP0010329_abnormal_lipoprotein_level | 1.11261137 |
| 72 | MP0009764_decreased_sensitivity_to | 1.10396827 |
| 73 | MP0002233_abnormal_nose_morphology | 1.09881554 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.09740326 |
| 75 | MP0002128_abnormal_blood_circulation | 1.08123817 |
| 76 | MP0005253_abnormal_eye_physiology | 1.07656411 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.07209960 |
| 78 | MP0001177_atelectasis | 1.05812164 |
| 79 | MP0003075_altered_response_to | 1.05016017 |
| 80 | MP0002108_abnormal_muscle_morphology | 1.03779213 |
| 81 | MP0002419_abnormal_innate_immunity | 1.03396151 |
| 82 | MP0004085_abnormal_heartbeat | 1.02445916 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.02344098 |
| 84 | MP0005165_increased_susceptibility_to | 1.02047367 |
| 85 | MP0000249_abnormal_blood_vessel | 1.01422065 |
| 86 | MP0010030_abnormal_orbit_morphology | 1.01193300 |
| 87 | MP0001661_extended_life_span | 0.99782789 |
| 88 | MP0001915_intracranial_hemorrhage | 0.99272551 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.98854200 |
| 90 | MP0002133_abnormal_respiratory_system | 0.98798688 |
| 91 | MP0005388_respiratory_system_phenotype | 0.98798688 |
| 92 | MP0004510_myositis | 0.97956871 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.95745763 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.95215898 |
| 95 | MP0000383_abnormal_hair_follicle | 0.94942354 |
| 96 | MP0002282_abnormal_trachea_morphology | 0.93542911 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.92757241 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.92404760 |
| 99 | MP0003045_fibrosis | 0.91483700 |
| 100 | MP0003448_altered_tumor_morphology | 0.91383232 |
| 101 | MP0001873_stomach_inflammation | 0.90324540 |
| 102 | MP0000778_abnormal_nervous_system | 0.89700586 |
| 103 | MP0002932_abnormal_joint_morphology | 0.89148456 |
| 104 | MP0001614_abnormal_blood_vessel | 0.89111723 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.88954773 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.88954773 |
| 107 | MP0001853_heart_inflammation | 0.88597237 |
| 108 | MP0005171_absent_coat_pigmentation | 0.88371879 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.87745623 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.86803090 |
| 111 | MP0000749_muscle_degeneration | 0.86344957 |
| 112 | MP0005670_abnormal_white_adipose | 0.86149793 |
| 113 | MP0000049_abnormal_middle_ear | 0.86099895 |
| 114 | MP0003115_abnormal_respiratory_system | 0.85955031 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.85604142 |
| 116 | MP0003634_abnormal_glial_cell | 0.84921801 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.83579528 |
| 118 | MP0003632_abnormal_nervous_system | 0.83076676 |
| 119 | MP0005365_abnormal_bile_salt | 0.82999771 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.82730008 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.82527157 |
| 122 | MP0005385_cardiovascular_system_phenoty | 0.82527157 |
| 123 | MP0004484_altered_response_of | 0.82390020 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.82030021 |
| 125 | MP0000747_muscle_weakness | 0.81783864 |
| 126 | MP0001175_abnormal_lung_morphology | 0.81762320 |
| 127 | * MP0002127_abnormal_cardiovascular_syste | 0.81756543 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.81451331 |
| 129 | MP0002115_abnormal_skeleton_extremities | 0.79427631 |
| 130 | MP0001790_abnormal_immune_system | 0.77676120 |
| 131 | MP0005387_immune_system_phenotype | 0.77676120 |
| 132 | MP0003795_abnormal_bone_structure | 0.77226980 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.76907824 |
| 134 | MP0006276_abnormal_autonomic_nervous | 0.76727730 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 0.76085579 |
| 136 | MP0002090_abnormal_vision | 0.75881916 |
| 137 | MP0001346_abnormal_lacrimal_gland | 0.75305032 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74995503 |
| 139 | MP0002113_abnormal_skeleton_development | 0.74640806 |
| 140 | MP0009278_abnormal_bone_marrow | 0.73893919 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.71646624 |
| 142 | MP0003755_abnormal_palate_morphology | 0.71201633 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.71173149 |
| 144 | MP0000428_abnormal_craniofacial_morphol | 0.69087430 |
| 145 | MP0000858_altered_metastatic_potential | 0.68879807 |
| 146 | MP0002925_abnormal_cardiovascular_devel | 0.68676107 |
| 147 | MP0006138_congestive_heart_failure | 0.67527570 |
| 148 | MP0002168_other_aberrant_phenotype | 0.66704135 |
| 149 | MP0002332_abnormal_exercise_endurance | 0.65432241 |
| 150 | MP0000534_abnormal_ureter_morphology | 0.65191348 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.64673104 |
| 152 | MP0009785_altered_susceptibility_to | 0.61258737 |
| 153 | MP0003942_abnormal_urinary_system | 0.59702650 |
| 154 | MP0001299_abnormal_eye_distance/ | 0.57978125 |
| 155 | MP0002972_abnormal_cardiac_muscle | 0.57560994 |
| 156 | MP0002405_respiratory_system_inflammati | 0.56925488 |
| 157 | MP0002006_tumorigenesis | 0.55318192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.78588924 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.32380474 |
| 3 | Broad metatarsal (HP:0001783) | 5.18293298 |
| 4 | Nonimmune hydrops fetalis (HP:0001790) | 4.84629097 |
| 5 | Complement deficiency (HP:0004431) | 4.56325573 |
| 6 | Follicular hyperkeratosis (HP:0007502) | 4.36966399 |
| 7 | Aortic dissection (HP:0002647) | 4.28352905 |
| 8 | Aortic aneurysm (HP:0004942) | 4.16430250 |
| 9 | Cerebral aneurysm (HP:0004944) | 4.04934226 |
| 10 | Short hallux (HP:0010109) | 4.02824432 |
| 11 | Soft skin (HP:0000977) | 3.87169453 |
| 12 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.78466963 |
| 13 | Abnormality of complement system (HP:0005339) | 3.77367636 |
| 14 | Bladder diverticulum (HP:0000015) | 3.66503761 |
| 15 | Vitreoretinal degeneration (HP:0000655) | 3.66084504 |
| 16 | Ankle contracture (HP:0006466) | 3.65139151 |
| 17 | Vascular tortuosity (HP:0004948) | 3.59651604 |
| 18 | Shallow orbits (HP:0000586) | 3.56848961 |
| 19 | Limited hip movement (HP:0008800) | 3.31383395 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.30659054 |
| 21 | Atrophic scars (HP:0001075) | 3.15333064 |
| 22 | Dilatation of the ascending aorta (HP:0005111) | 3.14142682 |
| 23 | Peritonitis (HP:0002586) | 3.08283034 |
| 24 | Biconcave vertebral bodies (HP:0004586) | 3.08189692 |
| 25 | Arterial tortuosity (HP:0005116) | 3.06731217 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 2.95552035 |
| 27 | Ventricular tachycardia (HP:0004756) | 2.93169129 |
| 28 | Hip contracture (HP:0003273) | 2.93131827 |
| 29 | Hematochezia (HP:0002573) | 2.91311719 |
| 30 | Cervical subluxation (HP:0003308) | 2.89234028 |
| 31 | Neonatal short-limb short stature (HP:0008921) | 2.86988468 |
| 32 | Glomerulonephritis (HP:0000099) | 2.82196694 |
| 33 | Wormian bones (HP:0002645) | 2.73851097 |
| 34 | Abnormality of dentin (HP:0010299) | 2.71189647 |
| 35 | Increased corneal curvature (HP:0100692) | 2.62941256 |
| 36 | Keratoconus (HP:0000563) | 2.62941256 |
| 37 | Blue sclerae (HP:0000592) | 2.56915979 |
| 38 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.55863052 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.53457990 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53457990 |
| 41 | Mitral valve prolapse (HP:0001634) | 2.53020052 |
| 42 | Vertebral clefting (HP:0008428) | 2.51696108 |
| 43 | Mitral stenosis (HP:0001718) | 2.50828498 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.49196219 |
| 45 | Abnormality of the diencephalon (HP:0010662) | 2.48806855 |
| 46 | Coronal craniosynostosis (HP:0004440) | 2.48071368 |
| 47 | Sensorimotor neuropathy (HP:0007141) | 2.47135940 |
| 48 | Myocardial infarction (HP:0001658) | 2.42465377 |
| 49 | Aplasia involving bones of the extremities (HP:0009825) | 2.42237773 |
| 50 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.42237773 |
| 51 | Aplasia of the phalanges of the hand (HP:0009802) | 2.42237773 |
| 52 | Patent foramen ovale (HP:0001655) | 2.39189226 |
| 53 | Visceral angiomatosis (HP:0100761) | 2.38485608 |
| 54 | Partial duplication of thumb phalanx (HP:0009944) | 2.38178221 |
| 55 | Aneurysm (HP:0002617) | 2.37549350 |
| 56 | Fragile skin (HP:0001030) | 2.37544550 |
| 57 | Metaphyseal cupping (HP:0003021) | 2.37108927 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.32956384 |
| 59 | Split foot (HP:0001839) | 2.32312786 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.29875581 |
| 61 | Bronchomalacia (HP:0002780) | 2.29761664 |
| 62 | Polyphagia (HP:0002591) | 2.28669845 |
| 63 | Metaphyseal dysplasia (HP:0100255) | 2.27491636 |
| 64 | Asymmetry of the thorax (HP:0001555) | 2.26863685 |
| 65 | Vertebral hypoplasia (HP:0008417) | 2.24538293 |
| 66 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.24538293 |
| 67 | Spondylolisthesis (HP:0003302) | 2.24434349 |
| 68 | Spinal rigidity (HP:0003306) | 2.22251202 |
| 69 | Overgrowth (HP:0001548) | 2.22194712 |
| 70 | Pulmonary artery stenosis (HP:0004415) | 2.18858590 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.18016793 |
| 72 | Alopecia of scalp (HP:0002293) | 2.16528972 |
| 73 | Turricephaly (HP:0000262) | 2.16452894 |
| 74 | Broad ribs (HP:0000885) | 2.15444791 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.15363312 |
| 76 | Hemangiomatosis (HP:0007461) | 2.14980945 |
| 77 | Sudden death (HP:0001699) | 2.14767022 |
| 78 | Spinal cord lesions (HP:0100561) | 2.14470874 |
| 79 | Syringomyelia (HP:0003396) | 2.14470874 |
| 80 | Broad hallux (HP:0010055) | 2.14359897 |
| 81 | Absent toe (HP:0010760) | 2.12218802 |
| 82 | Venous abnormality (HP:0002624) | 2.11443169 |
| 83 | Hyperextensible skin (HP:0000974) | 2.10504536 |
| 84 | Venous insufficiency (HP:0005293) | 2.09612095 |
| 85 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06698241 |
| 86 | Wrist flexion contracture (HP:0001239) | 2.06402095 |
| 87 | Partial duplication of the phalanx of hand (HP:0009999) | 2.04206784 |
| 88 | Chorioretinal atrophy (HP:0000533) | 2.03970149 |
| 89 | Broad toe (HP:0001837) | 2.03934471 |
| 90 | Type 1 muscle fiber predominance (HP:0003803) | 2.03126949 |
| 91 | Increased connective tissue (HP:0009025) | 2.03020612 |
| 92 | Genital tract atresia (HP:0001827) | 2.02696813 |
| 93 | Knee flexion contracture (HP:0006380) | 2.02434889 |
| 94 | Intrahepatic cholestasis (HP:0001406) | 2.00393306 |
| 95 | Hemiplegia (HP:0002301) | 1.99661475 |
| 96 | Atrial fibrillation (HP:0005110) | 1.99309820 |
| 97 | Short 4th metacarpal (HP:0010044) | 1.98975553 |
| 98 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.98975553 |
| 99 | Vaginal atresia (HP:0000148) | 1.98696877 |
| 100 | Mitral regurgitation (HP:0001653) | 1.98673009 |
| 101 | Short tibia (HP:0005736) | 1.97257187 |
| 102 | Ectopia lentis (HP:0001083) | 1.97076111 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 1.96974260 |
| 104 | Hemiparesis (HP:0001269) | 1.96566067 |
| 105 | Buphthalmos (HP:0000557) | 1.96432788 |
| 106 | Lymphangioma (HP:0100764) | 1.96392854 |
| 107 | Aortic valve stenosis (HP:0001650) | 1.96019652 |
| 108 | Craniofacial hyperostosis (HP:0004493) | 1.94592601 |
| 109 | Preaxial foot polydactyly (HP:0001841) | 1.93785606 |
| 110 | Megalencephaly (HP:0001355) | 1.93664698 |
| 111 | Infantile muscular hypotonia (HP:0008947) | 1.93350875 |
| 112 | Rectal prolapse (HP:0002035) | 1.91516373 |
| 113 | Genu recurvatum (HP:0002816) | 1.91390106 |
| 114 | Neurofibrillary tangles (HP:0002185) | 1.90842933 |
| 115 | Ileus (HP:0002595) | 1.90812639 |
| 116 | Abnormality of incisor morphology (HP:0011063) | 1.90721423 |
| 117 | Abnormality of the peritoneum (HP:0002585) | 1.90380922 |
| 118 | Tarsal synostosis (HP:0008368) | 1.88819583 |
| 119 | Joint laxity (HP:0001388) | 1.88558192 |
| 120 | Aortic regurgitation (HP:0001659) | 1.86377745 |
| 121 | Nephritis (HP:0000123) | 1.86098622 |
| 122 | Conjunctival telangiectasia (HP:0000524) | 1.85846954 |
| 123 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85783463 |
| 124 | Hypoplastic ischia (HP:0003175) | 1.85668586 |
| 125 | Camptodactyly of toe (HP:0001836) | 1.85262054 |
| 126 | Abnormality of skull ossification (HP:0002703) | 1.85010510 |
| 127 | Bell-shaped thorax (HP:0001591) | 1.83929678 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.83818000 |
| 129 | Lipoatrophy (HP:0100578) | 1.83770849 |
| 130 | Polycythemia (HP:0001901) | 1.82923227 |
| 131 | Cutaneous finger syndactyly (HP:0010554) | 1.82719478 |
| 132 | Ovoid vertebral bodies (HP:0003300) | 1.82295806 |
| 133 | Hydroxyprolinuria (HP:0003080) | 1.82022494 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 1.82022494 |
| 135 | Gingival overgrowth (HP:0000212) | 1.79991257 |
| 136 | Chondrocalcinosis (HP:0000934) | 1.79979945 |
| 137 | Alacrima (HP:0000522) | 1.79575399 |
| 138 | Short middle phalanx of the 5th finger (HP:0004220) | 1.79488140 |
| 139 | Hypoplasia of the iris (HP:0007676) | 1.77016516 |
| 140 | Tetraparesis (HP:0002273) | 1.77013987 |
| 141 | Epidermoid cyst (HP:0200040) | 1.76164965 |
| 142 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.75927240 |
| 143 | Short nail (HP:0001799) | 1.75724973 |
| 144 | Abnormality of the ischium (HP:0003174) | 1.74823284 |
| 145 | Asymmetric septal hypertrophy (HP:0001670) | 1.74329317 |
| 146 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.73386701 |
| 147 | Fibular hypoplasia (HP:0003038) | 1.73243027 |
| 148 | Mesomelia (HP:0003027) | 1.73128347 |
| 149 | Vascular calcification (HP:0004934) | 1.72330847 |
| 150 | Abnormality of Sharpey fibers (HP:0100685) | 1.72126132 |
| 151 | Capillary hemangiomas (HP:0005306) | 1.71953158 |
| 152 | Striae distensae (HP:0001065) | 1.71943285 |
| 153 | Thin ribs (HP:0000883) | 1.71633953 |
| 154 | Wide anterior fontanel (HP:0000260) | 1.70705194 |
| 155 | Left ventricular hypertrophy (HP:0001712) | 1.70248812 |
| 156 | Joint stiffness (HP:0001387) | 1.69784806 |
| 157 | Ulnar bowing (HP:0003031) | 1.69067565 |
| 158 | Diaphragmatic weakness (HP:0009113) | 1.68819148 |
| 159 | Facial shape deformation (HP:0011334) | 1.67581015 |
| 160 | Potter facies (HP:0002009) | 1.67581015 |
| 161 | Primary atrial arrhythmia (HP:0001692) | 1.65413169 |
| 162 | Congenital primary aphakia (HP:0007707) | 1.64202115 |
| 163 | Trigonocephaly (HP:0000243) | 1.63268872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 7.16503810 |
| 2 | TIE1 | 4.89708922 |
| 3 | TGFBR2 | 4.17201152 |
| 4 | PKN2 | 3.90171076 |
| 5 | OBSCN | 3.10265865 |
| 6 | PNCK | 3.05633568 |
| 7 | FLT3 | 2.88920370 |
| 8 | CASK | 2.59314889 |
| 9 | JAK1 | 2.36255858 |
| 10 | EPHA3 | 2.30502071 |
| 11 | EPHA4 | 2.28097420 |
| 12 | MAP3K14 | 2.13593817 |
| 13 | FGFR4 | 2.11191344 |
| 14 | TNIK | 2.05191808 |
| 15 | ERN1 | 2.03961708 |
| 16 | TTN | 1.98563621 |
| 17 | DDR2 | 1.97448513 |
| 18 | PTK2B | 1.96768090 |
| 19 | EPHB1 | 1.90349318 |
| 20 | STK38L | 1.86449810 |
| 21 | JAK3 | 1.78730683 |
| 22 | PDGFRA | 1.66092539 |
| 23 | BMX | 1.63876709 |
| 24 | EPHB2 | 1.61679632 |
| 25 | TYK2 | 1.57966791 |
| 26 | PTK6 | 1.57424878 |
| 27 | MYLK | 1.49491412 |
| 28 | TGFBR1 | 1.42932479 |
| 29 | SIK1 | 1.41542945 |
| 30 | CAMK1G | 1.40102967 |
| 31 | MET | 1.38556598 |
| 32 | NTRK2 | 1.38052706 |
| 33 | LMTK2 | 1.30868449 |
| 34 | STK39 | 1.30812074 |
| 35 | NTRK1 | 1.30509113 |
| 36 | FGFR3 | 1.30117803 |
| 37 | FRK | 1.28973850 |
| 38 | MOS | 1.23459480 |
| 39 | BMPR1B | 1.20098819 |
| 40 | BCR | 1.17944457 |
| 41 | TBK1 | 1.17254969 |
| 42 | KIT | 1.14004172 |
| 43 | FER | 1.11401692 |
| 44 | DMPK | 1.09966232 |
| 45 | TRIB3 | 1.08473620 |
| 46 | RIPK1 | 1.06460825 |
| 47 | ERBB3 | 1.06326244 |
| 48 | ROCK1 | 1.06285430 |
| 49 | PTK2 | 1.03941921 |
| 50 | MKNK2 | 1.01536752 |
| 51 | PAK2 | 1.01122817 |
| 52 | CAMK1D | 1.00797953 |
| 53 | TRPM7 | 0.99266663 |
| 54 | JAK2 | 0.91932042 |
| 55 | CSF1R | 0.91903790 |
| 56 | STK10 | 0.90926920 |
| 57 | LATS1 | 0.89725200 |
| 58 | CLK1 | 0.89402693 |
| 59 | NEK9 | 0.88885232 |
| 60 | CAMK4 | 0.83794600 |
| 61 | IKBKB | 0.81500573 |
| 62 | NTRK3 | 0.79627759 |
| 63 | CHUK | 0.78876658 |
| 64 | FGR | 0.77826855 |
| 65 | IKBKE | 0.76150539 |
| 66 | PDGFRB | 0.75525187 |
| 67 | PINK1 | 0.73617039 |
| 68 | EIF2AK2 | 0.73368490 |
| 69 | NUAK1 | 0.72886366 |
| 70 | RPS6KA4 | 0.71206882 |
| 71 | CSK | 0.69690756 |
| 72 | PAK3 | 0.68035742 |
| 73 | GRK1 | 0.65611990 |
| 74 | INSR | 0.65234261 |
| 75 | CDC42BPA | 0.65011290 |
| 76 | MAPKAPK3 | 0.64608104 |
| 77 | IRAK1 | 0.64596660 |
| 78 | IGF1R | 0.64393257 |
| 79 | CDK9 | 0.64178565 |
| 80 | CAMK2D | 0.63724423 |
| 81 | PAK4 | 0.63599836 |
| 82 | PIK3CA | 0.62847892 |
| 83 | PAK6 | 0.62741196 |
| 84 | MUSK | 0.61116609 |
| 85 | ERBB2 | 0.60789865 |
| 86 | PRKD1 | 0.60300066 |
| 87 | CSNK1G1 | 0.60041414 |
| 88 | RET | 0.59565945 |
| 89 | LRRK2 | 0.58062953 |
| 90 | CAMK2G | 0.56714862 |
| 91 | MAP3K2 | 0.56421489 |
| 92 | TSSK6 | 0.56172341 |
| 93 | MAP2K1 | 0.56050631 |
| 94 | STK3 | 0.55082889 |
| 95 | GRK7 | 0.54057509 |
| 96 | MAPK7 | 0.53966680 |
| 97 | ADRBK1 | 0.53739388 |
| 98 | FGFR2 | 0.52926334 |
| 99 | PRKG2 | 0.52566019 |
| 100 | ZAK | 0.52405681 |
| 101 | DYRK3 | 0.52404608 |
| 102 | BCKDK | 0.52395480 |
| 103 | SGK2 | 0.51263049 |
| 104 | KSR1 | 0.50389933 |
| 105 | EGFR | 0.50302819 |
| 106 | SRC | 0.50265450 |
| 107 | MAP3K6 | 0.47650052 |
| 108 | MAPK12 | 0.47496093 |
| 109 | MAPK15 | 0.47382451 |
| 110 | PRKCE | 0.47199941 |
| 111 | CAMK2A | 0.46805541 |
| 112 | MAP3K10 | 0.45347342 |
| 113 | PRKACG | 0.45121386 |
| 114 | MKNK1 | 0.44185701 |
| 115 | CSNK1A1L | 0.43953903 |
| 116 | PRKAA2 | 0.43902247 |
| 117 | NLK | 0.43870698 |
| 118 | CSNK1G2 | 0.42544486 |
| 119 | PLK2 | 0.42071991 |
| 120 | PHKG1 | 0.41081407 |
| 121 | PHKG2 | 0.41081407 |
| 122 | PKN1 | 0.39316700 |
| 123 | PIK3CG | 0.39277575 |
| 124 | WNK3 | 0.38829811 |
| 125 | PRKD3 | 0.38086415 |
| 126 | PRKCH | 0.37429634 |
| 127 | PRKG1 | 0.37273248 |
| 128 | FGFR1 | 0.37008484 |
| 129 | WEE1 | 0.36560803 |
| 130 | BMPR2 | 0.36352570 |
| 131 | IRAK3 | 0.36229074 |
| 132 | LYN | 0.36172024 |
| 133 | ILK | 0.35735350 |
| 134 | STK38 | 0.34153598 |
| 135 | PDK2 | 0.33358835 |
| 136 | MAPKAPK2 | 0.31942010 |
| 137 | YES1 | 0.31896655 |
| 138 | INSRR | 0.31578630 |
| 139 | ROCK2 | 0.31546191 |
| 140 | RAF1 | 0.31532692 |
| 141 | SGK223 | 0.31257778 |
| 142 | SGK494 | 0.31257778 |
| 143 | MAP3K5 | 0.31178798 |
| 144 | GSK3A | 0.30949264 |
| 145 | MAPK13 | 0.30437002 |
| 146 | LATS2 | 0.29614059 |
| 147 | STK24 | 0.29281767 |
| 148 | MARK1 | 0.28784348 |
| 149 | CDK8 | 0.28782348 |
| 150 | PRKCD | 0.27797005 |
| 151 | MAPK3 | 0.27599477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.41264052 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.17495896 |
| 3 | * Malaria_Homo sapiens_hsa05144 | 3.07652346 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.05694458 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80717174 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.76030099 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.68833901 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.62833723 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.60106094 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.12356336 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11919619 |
| 12 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.00329148 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97120702 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79940447 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69734430 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.66780570 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.66709414 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.65278928 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.62513329 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61066396 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59923672 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.57877127 |
| 23 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.55959858 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55722834 |
| 25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.53865919 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53632557 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49579180 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47458525 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45285347 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43293452 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42569045 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41222636 |
| 33 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39774034 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39368151 |
| 35 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.36797220 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33285684 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.27478909 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27276993 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26474347 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26204577 |
| 41 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.26007963 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25173327 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23776213 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.22810180 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.18811141 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18113863 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16709724 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.15645529 |
| 49 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11619409 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10488675 |
| 51 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.06349000 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05263747 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04006085 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.02067868 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.02058087 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00949065 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99108735 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95320929 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94160577 |
| 60 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92992857 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92762864 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91389938 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90318264 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90081603 |
| 65 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89718765 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88723111 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87999865 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87865575 |
| 69 | Pathways in cancer_Homo sapiens_hsa05200 | 0.87768366 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86519806 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86072417 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84519863 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83263091 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.82801800 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.82653084 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82251936 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.81969397 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81517211 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81348231 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80694752 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79763923 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79596283 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.79471372 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78298260 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78118733 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.77422823 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.75520416 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75089890 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74529226 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74496261 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.74073978 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.72672962 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70774611 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70525420 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.70455207 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70018982 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68922424 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.68885694 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68586169 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.66986559 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66606247 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.66337254 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65097156 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64915572 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64769573 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64555833 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63446475 |
| 108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62961713 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62715621 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.61944015 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.61256811 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60776538 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60662975 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60626391 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60084620 |
| 116 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.59451979 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59443865 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59240174 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58275407 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57230932 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57020065 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56953455 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56937121 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56131707 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.54532559 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.54259229 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52555415 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52356924 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.50868572 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50566049 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49555135 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49140069 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48302675 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48199559 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47942234 |
| 136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47549878 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47083629 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.46544876 |
| 139 | Axon guidance_Homo sapiens_hsa04360 | 0.46115557 |
| 140 | Prostate cancer_Homo sapiens_hsa05215 | 0.45738264 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45439372 |
| 142 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44691570 |
| 143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44135868 |
| 144 | Renin secretion_Homo sapiens_hsa04924 | 0.43533520 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43393659 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.43261046 |
| 147 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42648099 |
| 148 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42343533 |
| 149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40394883 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39761031 |
| 151 | Asthma_Homo sapiens_hsa05310 | 0.36942357 |
| 152 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36215463 |
| 153 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35952060 |
| 154 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30481157 |
| 155 | Lysine degradation_Homo sapiens_hsa00310 | 0.29126497 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27002827 |

